Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Products>This Product
  Products


Sandoz

Product Description

Sandoz is a world leading manufacturer of biotechnological products. Our expertise stems from decades of experience in this complex field, particularly in the production of intermediates for third parties. Early successes were marked by the production of the first-ever oral penicillin in 1951 (anti-infectives), and one of the first recombinant proteins, an interferon, in 1980 (biopharmaceuticals).

Over the years, our role has evolved from simply a contract manufacturer to a full-service provider, i.e. providing solutions for all steps in the value chain of a project through to building strong relationships with our partners. Underlying this role is trust – trust in the shared values of a global company, trust in the innovative solutions we provide, and trust in the quality of our products and services on the back of our long history and industry know-how.

Sandoz has traditionally been among the leading specialists in microbial fermentation of classic and recombinant microorganisms. Our comprehensive know-how is based on several decades of experience in the fields of classical microbial products and recombinant microbial production at a commercial scale. In 2004, we successfully extended our production technology into the field of mammalian cell culture.

Today, we are a fully integrated manufacturer of recombinant products. We provide customized solutions for our partners that span the entire value chain, from development to production and fill and finish to customers. The flexibility in production capabilities to fully integrated services offers a variety of options when it comes to scaling different phases of development and commercial manufacturing, furthering the cost advantage to customers.

Sandoz is currently engaged in biotech cooperations with a number of leading organizations and continuously looks to extend its number of partnerships in the future. This strong experience combined with a successful track record of accomplishments and state-of-the-art plants, offers a unique opportunity to partners interested in pursuing manufacturing cooperations.

Product Sandoz
Company Sandoz
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Sandoz
Industriestrasse 25 83607 Holzkirchen Germany

Tel: +49 (0) 8024 476-0
Fax: +49 (0) 8024 476-2599
Email: info.sandoz@sandoz.com



Scientific News
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
Immunotherapy Agent Benefits Patients with Drug-Resistant Multiple Myeloma in First Human Trial
Daratumumab proved generally safe in patients, even at the highest doses.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Less May Be More in Slowing Cholera Epidemics
Mathematical model shows more cases may be prevented and more lives saved when using one dose of cholera vaccine instead of recommended two doses.
Investigating the Vape
Expert independent review concludes that e-cigarettes have potential to help smokers quit.
NIH Launches Human RSV Study
Study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Researchers Discover Synthesis of a New Nanomaterial
Interdisciplinary team creates biocomposite for first time using physiological conditions.
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Flu Remedies Help Combat E. coli Bacteria
Physiologists from the University of Zurich have now discovered why the intestinal bacterium Escherichia coli (E. coli) multiplies heavily and has an inflammatory effect.
Scroll Up
Scroll Down

Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!